| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 31 |
| 1 | FLUDARABINE PHOSPHATE | 28 |
| 2 | TACROLIMUS | 27 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 4 | TACROLIMUS OINTMENT 0.1% | 25 |
| 5 | OMEPRAZOLE MAGNESIUM | 23 |
| 6 | LEVOTHYROXINE SODIUM | 22 |
| 7 | OMEPRAZOLE | 22 |
| 8 | RITUXIMAB | 20 |
| 9 | CYCLOSPORINE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 12 | 0.0043 |
| 1 | PEGVISOMANT | 15 | 0.0037 |
| 2 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 3 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 4 | THIOTEPA | 16 | 0.0016 |
| 5 | PRIMIDONE | 15 | 0.0015 |
| 6 | BODY CLEANSER | 1 | 0.0014 |
| 7 | MARALIXIBAT CHLORIDE | 1 | 0.0010 |
| 8 | CLEAR MINT, GEL TOOTHPASTE | 1 | 0.0009 |
| 9 | SODIUM FLUORIDE F18 | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 70 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 2 | Proton Pump Inhibitor [EPC] | 32 |
| 3 | Alkylating Drug [EPC] | 27 |
| 4 | Thalidomide Analog [EPC] | 25 |
| 5 | Atypical Antipsychotic [EPC] | 23 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 20 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 19 |
| 8 | Anti-epileptic Agent [EPC] | 18 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 15 | 0.0008 |
| 2 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 3 | Androgen [EPC] | 11 | 0.0004 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 6 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 19 | 0.0001 |
| 9 | Somatostatin Analog [EPC] | 1 | 0.0001 |